Tenet Healthcare (THC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $267.25, -2.86% vs the prior close of $275.13.
- Volume 827.55K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
THC dips 2.9% to $267.25. Closed at $267.25, -2.86% vs the prior close of $275.13. Day range $265.67–$278.39, opened at $276.96.
THC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — THC dips 2.9% to $267.25
- Closed at $267.25, -2.86% vs the prior close of $275.13. Day range $265.67–$278.39, opened at $276.96.
- Volume was 827.55K shares, 1.2x its 50-day average of 714.35K.
- Price is +1.1% vs its 50-day average ($264.25) and +23.3% vs its 200-day average ($216.82).
- 52-week range $157.58–$283.05; today's close sits at 87% of that range, 5.6% below the 52-week high.
Oct 15, 2026 — THC rises 1.3% to $275.13, a 1-month high
- Closed at $275.13, +1.30% vs the prior close of $271.60. Day range $273.76–$277.60, opened at $274.83.
- Volume was 676.90K shares, 0.9x its 50-day average of 722.84K.
- Price is +4.2% vs its 50-day average ($264.04) and +27.1% vs its 200-day average ($216.50).
- 52-week range $157.58–$283.05; today's close sits at 94% of that range, 2.8% below the 52-week high.
Oct 14, 2026 — THC rises 1.8% to $271.60, a 1-month high
- Closed at $271.60, +1.76% vs the prior close of $266.91. Day range $267.71–$274.10, opened at $267.93.
- Volume was 717.30K shares, 1.0x its 50-day average of 730.27K.
- Price is +3.0% vs its 50-day average ($263.77) and +25.7% vs its 200-day average ($216.13).
- 52-week range $157.58–$283.05; today's close sits at 91% of that range, 4.0% below the 52-week high.
Oct 13, 2026 — THC dips 0.7% to $266.91
- Closed at $266.91, -0.69% vs the prior close of $268.76. Day range $265.45–$269.30, opened at $268.64.
- Volume was 600.00K shares, 0.8x its 50-day average of 741.47K.
- Price is +1.3% vs its 50-day average ($263.40) and +23.7% vs its 200-day average ($215.77).
- 52-week range $157.58–$283.05; today's close sits at 87% of that range, 5.7% below the 52-week high.
Oct 12, 2026 — THC rises 1.9% to $268.76, a 1-month high, 4 up days in a row
- Closed at $268.76, +1.89% vs the prior close of $263.78. Day range $264.32–$270.07, opened at $264.32.
- Volume was 509.10K shares, 0.7x its 50-day average of 753.25K.
- Price is +2.2% vs its 50-day average ($263.06) and +24.8% vs its 200-day average ($215.42).
- 52-week range $157.58–$283.05; today's close sits at 89% of that range, 5.0% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — THC rises 1.2% to $263.78, 3 up days in a row
- Closed at $263.78, +1.23% vs the prior close of $260.57. Day range $259.83–$265.98, opened at $259.83.
- Volume was 525.30K shares, 0.7x its 50-day average of 767.28K.
- Price is +0.4% vs its 50-day average ($262.79) and +22.6% vs its 200-day average ($215.07).
- 52-week range $157.58–$283.05; today's close sits at 85% of that range, 6.8% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — THC ends flat (+0.3%) to $260.57
- Closed at $260.57, +0.28% vs the prior close of $259.83. Day range $257.27–$262.69, opened at $257.27.
- Volume was 440.10K shares, 0.6x its 50-day average of 784.16K — lighter than usual.
- Price is -0.8% vs its 50-day average ($262.56) and +21.3% vs its 200-day average ($214.75).
- 52-week range $157.58–$283.05; today's close sits at 82% of that range, 7.9% below the 52-week high.
Oct 7, 2026 — THC rises 0.5% to $259.83
- Closed at $259.83, +0.53% vs the prior close of $258.47. Day range $256.45–$261.58, opened at $256.45.
- Volume was 475.50K shares, 0.6x its 50-day average of 811.28K — lighter than usual.
- Price is -1.0% vs its 50-day average ($262.51) and +21.2% vs its 200-day average ($214.43).
- 52-week range $157.58–$283.05; today's close sits at 81% of that range, 8.2% below the 52-week high.
Oct 6, 2026 — THC dips 0.4% to $258.47
- Closed at $258.47, -0.39% vs the prior close of $259.47. Day range $257.06–$263.46, opened at $260.72.
- Volume was 426.80K shares, 0.5x its 50-day average of 847.12K — lighter than usual.
- Price is -1.6% vs its 50-day average ($262.56) and +20.7% vs its 200-day average ($214.11).
- 52-week range $157.58–$283.05; today's close sits at 80% of that range, 8.7% below the 52-week high.
Oct 5, 2026 — THC rises 0.3% to $259.47
- Closed at $259.47, +0.33% vs the prior close of $258.62. Day range $258.75–$264.45, opened at $259.00.
- Volume was 692.90K shares, 0.7x its 50-day average of 926.05K.
- Price is -1.1% vs its 50-day average ($262.26) and +21.4% vs its 200-day average ($213.79).
- 52-week range $157.58–$283.05; today's close sits at 81% of that range, 8.3% below the 52-week high.
Oct 2, 2026 — THC rises 1.8% to $258.62
- Closed at $258.62, +1.83% vs the prior close of $253.97. Day range $254.98–$260.99, opened at $255.38.
- Volume was 574.60K shares, 0.6x its 50-day average of 950.05K.
- Price is -1.2% vs its 50-day average ($261.73) and +21.1% vs its 200-day average ($213.48).
- 52-week range $157.58–$283.05; today's close sits at 81% of that range, 8.6% below the 52-week high.
THC latest news & SEC filings
Every SEC filing by or about THC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kerrey J Robert sold 5,483 shares at $263.04 (≈$1.44M) on Sep 14, 2026; now holds 11,321
- Kerrey J Robert sold 4,025 shares at $264.10 (≈$1.06M) on Sep 14, 2026; now holds 7,296
- Kerrey J Robert sold 2,502 shares at $264.62 (≈$662.08K) on Sep 14, 2026; now holds 4,794
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mark Richard J sold 10,000 shares at $263.42 (≈$2.63M) on Sep 10, 2026
- Mark Richard J sold 10,000 shares at $263.42 (≈$2.63M) on Sep 10, 2026
- Mark Richard J sold 10,000 shares at $263.42 (≈$2.63M) on Sep 10, 2026
- Mark Richard J sold 10,000 shares at $263.42 (≈$2.63M) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 4, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- West Nadja sold 1,152 shares at $258.80 (≈$298.14K) on Sep 2, 2026
- West Nadja sold 1,152 shares at $258.80 (≈$298.14K) on Sep 2, 2026
- West Nadja sold 1,152 shares at $258.80 (≈$298.14K) on Sep 2, 2026
- West Nadja sold 1,152 shares at $258.80 (≈$298.14K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $5.63B (prior year $5.27B) (+6.8% vs Jun 30, 2025)
- Diluted EPS: $9.84 (prior year $3.14) (+213.4% vs Jun 30, 2025)
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade THC
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 11, 2026, Feb 2, 2026. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.25% (largest 4.1%).
- Liquidity: about 593.37K shares (≈$158.58M) trade per day on average.
- 52-week position: $267.25 vs a range of $157.58–$283.05 (87% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: J Robert Kerrey sold 2,502 shares on Sep 14, 2026.
- Latest filings: 8-K Sep 22, 2026; 8-K Sep 8, 2026; 10-Q Jul 29, 2026.
- Share count: 80.52M shares outstanding (Jul 24, 2026), -8.9% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-General Medical & Surgical Hospitals, NEC.
THC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 276.96 | 278.39 | 265.67 | 267.25 | 827.55K |
| Oct 15, 2026 | 274.83 | 277.60 | 273.76 | 275.13 | 676.90K |
| Oct 14, 2026 | 267.93 | 274.10 | 267.71 | 271.60 | 717.30K |
| Oct 13, 2026 | 268.64 | 269.30 | 265.45 | 266.91 | 600.00K |
| Oct 12, 2026 | 264.32 | 270.07 | 264.32 | 268.76 | 509.10K |
| Oct 9, 2026 | 259.83 | 265.98 | 259.83 | 263.78 | 525.30K |
| Oct 8, 2026 | 257.27 | 262.69 | 257.27 | 260.57 | 440.10K |
| Oct 7, 2026 | 256.45 | 261.58 | 256.45 | 259.83 | 475.50K |
| Oct 6, 2026 | 260.72 | 263.46 | 257.06 | 258.47 | 426.80K |
| Oct 5, 2026 | 259.00 | 264.45 | 258.75 | 259.47 | 692.90K |
| Oct 2, 2026 | 255.38 | 260.99 | 254.98 | 258.62 | 574.60K |
| Oct 1, 2026 | 255.71 | 260.65 | 252.12 | 253.97 | 439.30K |
| Sep 30, 2026 | 257.58 | 260.46 | 255.53 | 255.56 | 577.20K |
| Sep 29, 2026 | 257.41 | 259.89 | 254.21 | 257.60 | 448.10K |
| Sep 28, 2026 | 258.00 | 265.64 | 256.85 | 257.93 | 541.50K |
| Sep 25, 2026 | 248.89 | 260.97 | 248.86 | 259.71 | 735.10K |
| Sep 24, 2026 | 258.55 | 259.51 | 249.38 | 249.54 | 575.80K |
| Sep 23, 2026 | 262.55 | 263.97 | 255.41 | 256.44 | 631.60K |
| Sep 22, 2026 | 263.06 | 265.20 | 261.30 | 262.06 | 781.90K |
| Sep 21, 2026 | 261.93 | 263.58 | 258.02 | 260.97 | 670.80K |
About Tenet Healthcare
Tenet Healthcare (THC) is listed on the NYSE and classified by the SEC under “Services-General Medical & Surgical Hospitals, NEC”. Its business address is in DALLAS, TX. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 70318.
THC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Vineeta Agarwala | Director | May 28, 2026 |
| James L Bierman | Director | Jul 28, 2026 |
| Roy Blunt | Director | Aug 7, 2026 |
| Richard W Fisher | Director | May 28, 2026 |
| Meghan Fitzgerald | Director | May 28, 2026 |
| Cecil D Haney | Director | Aug 31, 2026 |
| J Robert Kerrey | Director | Sep 16, 2026 |
| Christopher S. Lynch | Director | Jul 28, 2026 |
| Richard J Mark | Director | Sep 14, 2026 |
| Tammy Romo | Director | Aug 10, 2026 |
| Saumya Sutaria | CEO | Aug 26, 2026 |
| Nadja West | Director | Sep 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paola M Arbour | EVP, Chief Information Officer | Jul 28, 2026 |
| Thomas W Arnst | EVP, Chief Admin. Officer & GC | Mar 10, 2026 |
| Lisa Y Foo | EVP, Chief Operating Officer | Sep 1, 2026 |
| John Michael Grooms | Principal Accounting Officer | May 8, 2026 |
| Michael T. Maloney | EVP, Corporate Development | Mar 9, 2026 |
| Sun Park | EVP & Chief Financial Officer | Mar 3, 2026 |
| R. Scott Ramsey | Principal Accounting Officer | Mar 3, 2026 |
| Saumya Sutaria | CEO | Aug 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | J Robert Kerrey | Sale | 2,502 | $264.62 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 5,483 | $263.04 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 4,025 | $264.10 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 2,502 | $264.62 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 5,483 | $263.04 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 4,025 | $264.10 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 2,502 | $264.62 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 5,483 | $263.04 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 4,025 | $264.10 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 2,502 | $264.62 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 5,483 | $263.04 |
| Sep 14, 2026 | J Robert Kerrey | Sale | 4,025 | $264.10 |
| Sep 10, 2026 | Richard J Mark | Sale | 10,000 | $263.42 |
| Sep 10, 2026 | Richard J Mark | Sale | 10,000 | $263.42 |
| Sep 10, 2026 | Richard J Mark | Sale | 10,000 | $263.42 |
THC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $21.31B | — | 15.49 | $3.54B |
| Dec 31, 2024 | $20.68B | — | 32.70 | $2.05B |
| Dec 31, 2023 | $20.56B | — | 5.71 | $2.37B |
| Dec 31, 2022 | $19.17B | — | 3.79 | $1.08B |
| Dec 31, 2021 | $19.48B | — | 8.42 | $1.57B |
Latest balance sheet: total assets $30.68B, total liabilities $21.98B, cash $2.17B (as of Jun 30, 2026).
THC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $199.02 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $177.12 |
| Feb 11, 2026 | 8-K Item 2.02 (results) | $226.35 |
| Feb 2, 2026 | 8-K Item 2.02 (results) | $188.03 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $204.62 |
| Jul 22, 2025 | 8-K Item 2.02 (results) | $155.97 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $138.35 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $126.19 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $162.76 |
| Jul 24, 2024 | 8-K Item 2.02 (results) | — |
| Apr 30, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-General Medical & Surgical Hospitals, NEC
HCA Healthcare (HCA)Universal Health Services (UHS)Surgery Partners (SGRY)Ardent Health (ARDT)Community Health Systems (CYH)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on THC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.